Fig. 2.
Trends in disease modifying therapy (DMT) pricing. Pricing estimated from WAC for year of therapy. Alemtuzumab estimate is based on average of first- (60 mg) and second-year dose (36 mg)
IFN = interferon; SC = subcutaneous
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.